López et al., 2005 - Google Patents
Design, synthesis, and biological characterization of potential antiatherogenic nitric oxide releasing tocopherol analogsLópez et al., 2005
View PDF- Document ID
- 7704711288881812287
- Author
- López G
- Batthyány C
- Blanco F
- Botti H
- Trostchansky A
- Migliaro E
- Radi R
- González M
- Cerecetto H
- Rubbo H
- Publication year
- Publication venue
- Bioorganic & medicinal chemistry
External Links
Snippet
Synthesis and biological characterization of a series of α-tocopherol analogs with NO- releasing capacity are reported. The selected NO-donor moieties were nitrooxy and furoxan. All products were tested for their in vitro NO-releasing capacities, vasodilating properties …
- 230000015572 biosynthetic process 0 title abstract description 16
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulfur atoms in positions 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulfur atoms in positions 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/04—Five-membered rings having the hetero atoms in position 1,2, e.g. lipoic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2103/00—Systems containing at least three condensed rings
- C07C2103/02—Ortho- or ortho- and peri-condensed systems
- C07C2103/04—Ortho- or ortho- and peri-condensed systems containing three rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2101/00—Systems containing only non-condensed rings
- C07C2101/12—Systems containing only non-condensed rings with a six-membered ring
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| López et al. | Design, synthesis, and biological characterization of potential antiatherogenic nitric oxide releasing tocopherol analogs | |
| Freire et al. | Synthesis and antioxidant, anti-inflammatory and gastroprotector activities of anethole and related compounds | |
| EP1856085B1 (en) | Flavonoid compounds and uses thereof | |
| EP1877097B1 (en) | Aminoacid conjugates of beta-lapachone for tumor targeting | |
| US8816122B2 (en) | Prostratin analogs, bryostatin analogs, prodrugs, synthetic methods, and methods of use | |
| JP6321788B2 (en) | Production of (S, S) -secoisolaricylesinol diglucoside and (R, R) -secoisolaricylesinol diglucoside | |
| Yin et al. | Discovery of a ring-opened derivative of 3-n-butylphthalide bearing NO/H2S-donating moieties as a potential anti-ischemic stroke agent | |
| CA2502975A1 (en) | Chromones and chromone derivatives and uses thereof | |
| IE59143B1 (en) | Pharmaceutical compositions containing ascorbic acid derivatives | |
| Chinthakindi et al. | Diminutive effect on T and B-cell proliferation of non-cytotoxic α-santonin derived 1, 2, 3-triazoles: A report | |
| CN101362702A (en) | Emodin derivatives and their application in the preparation of anticancer drugs | |
| NZ546043A (en) | Dianhydrohexite mononitrate derivatives of cyclic sugars and uses thereof | |
| CA2553953A1 (en) | Therapeutic use of quinonoid derivatives of cannabinoids | |
| FI90545C (en) | Process for the preparation of therapeutically active 2,2-dimethyl chromene derivatives | |
| Gao et al. | Design, synthesis and biological evaluation of novel hydrogen sulfide releasing capsaicin derivatives | |
| CN105294666B (en) | A kind of Danshensu derivatives and preparation method thereof and medical applications | |
| CN115286633B (en) | Synthesis of a class of targeting protein chimeras with antitumor activity and their application as antitumor drugs | |
| EP3252039B1 (en) | Compound containing indoleacetic acid core structure and use thereof | |
| Irfan et al. | Molecular level interaction, HOMO-LUMO, MEP, UV–Vis, Hirshfeld, topological analysis, and in-vitro of isoflavones from Eremostachys Vicaryi Benth. Ex Hook. f. | |
| CN100528869C (en) | Silybin flavonolignan and their production method and use | |
| CN111362837A (en) | NQO1 activated Combretastatin A4 prodrug and synthesis method and application thereof | |
| CN113461563B (en) | NQO1-activated 6-diazo-5-oxo-L-norleucine prodrug and preparation method and application thereof | |
| Kancheva et al. | Protective effects of 4-methylcoumarins and related compounds as radical scavengers and chain-breaking antioxidants | |
| Godfroid et al. | Structure-activity relationship in PAF-acether. 3. Hydrophobic contribution to agonistic activity | |
| Kovačević et al. | Synthesis and in vitro antitumour activity of crassalactone D, its stereoisomers and novel cinnamic ester derivatives |